Evidence map›Paper›PMID 9620991›Full record

ArticleJournal of virology1998

Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage.

R Jordan, J Pepe, P A Schaffer

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

R JordanDivision of Molecular Genetics, Dana-Farber Cancer Institute, and Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Pepe
P A Schaffer
Dana-Farber Cancer Institute · USHarvard University · US

Funding

VIRAL AND CELLULAR GENES IN HSV LATENCY AND REACTIVATIONP01NS035138 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI SCHAFFER, PRISCILLA A · 1996 to 2010
$15.0M
IMMEDIATE-EARLY GENES OF HSVR01CA020260 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BRINGHURST, RYAN M · 1985 to 2008
$3.7M
ICPO RESPONSE ELEMENTS IN THE 5'LEADERS OF HSV 1 GENESF32AI009127 · NIAID · DANA-FARBER CANCER INSTITUTE · PI JORDAN, ROBERT · 1994 to 1995
–
IMMEDIATE-EARLY GENES OF HSVR37CA020260 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SCHAFFER, PRISCILLA A · 1990 to 1997
–
NCI NIH HHS R01 CA020260NCI NIH HHS R37CA20260NIAID NIH HHS F32 AI009127NIAID NIH HHS F32 AI09127NINDS NIH HHS P0INS35138
6 · The paper itself

Abstract

Herpes simplex virus type 1 (HSV-1) ICP0 is required for efficient viral gene expression during lytic infection, especially at low multiplicities. A series of cellular activities that can substitute for ICP0 has been identified, suggesting that when the activity of ICP0 is limiting, these activities can substitute for ICP0 to activate viral gene expression. The cellular activities may be especially important during reactivation of HSV from neuronal latency when viral gene expression is initiated in the absence of prior viral protein synthesis. Consistent with this hypothesis, we have identified an inducible activity in cells of neural lineage (PC12) that can complement the low-multiplicity growth phenotype of an ICP0 null mutant, n212. Pretreatment of PC12 cells with nerve growth factor (NGF) or fibroblast growth factor (FGF) prior to infection produced a 10- to 20-fold increase in the 24-h yield of n212 but only a 2- to 4-fold increase in the yield of wild-type virus relative to mock treatment. Slot blot analysis of nuclear DNA isolated from infected cells treated or mock treated with NGF indicated that NGF treatment does not significantly affect viral entry. The NGF-induced activity in PC12 cells was expressed transiently, with peak complementing activity observed when cells were treated with NGF 12 h prior to infection. Addition of NGF 3 h after infection had little effect on virus yield. The NGF-induced cellular activity was inhibited by pretreatment of PC12 cells with kinase inhibitors that have high specificity for kinases involved in NGF/FGF-dependent signal transduction. RNase protection assays demonstrated that the NGF-inducible PC12 cell activity, like that of ICP0, functions to increase the level of viral mRNA during low-multiplicity infection. These results suggest that activation of viral transcription by ICP0 and transcriptional activation of cellular genes by NGF and FGF utilize common signal transduction pathways in PC12 cells.

Indexed as

AnimalsCyclic AMPFibroblast Growth FactorsHerpesvirus 1, HumanImmediate-Early ProteinsNerve Growth FactorsPC12 CellsPhosphorylationRatsRNA, ViralSignal TransductionTranscriptional ActivationUbiquitin-Protein LigasesVirus ReplicationCyclic AMPFibroblast Growth FactorsImmediate-Early ProteinsNerve Growth FactorsRNA, ViralUbiquitin-Protein LigasesVmw110 protein, Human herpesvirus 1

Identifiers

PMID9620991
PMCPMC110163
OpenAlexW2172298459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.